Case File №
#VI-2026-0755
Evolve BioPep
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
44 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Tirzepatide | C Okay | 6 | 6.2 | 4.9 | 8.0 | 2 Jul 2025 |
| Tesamorelin | X Unrated | 1 | 5.5 | 5.5 | 5.5 | 27 Jun 2025 |
| 1-Boc-4-AP (tert-butyl 4-(phenylamino)piperidine-1-carboxylate) CAS 125541-22-2 | X N/A | 1 | 6.2 | 6.2 | 6.2 | 24 Apr 2025 |
| 1-Testosterone Cypionate (DHB) Raw | X N/A | 1 | 5.3 | 5.3 | 5.3 | 17 Dec 2024 |
| 5-amino-1MQ | X N/A | 1 | 4.8 | 4.8 | 4.8 | 25 Apr 2025 |
| Adipotide | X N/A | 1 | 6.3 | 6.3 | 6.3 | 13 Feb 2025 |
| AICAR | X N/A | 1 | 4.7 | 4.7 | 4.7 | 13 Jun 2025 |
| Alprostadil | X N/A | 1 | 6.7 | 6.7 | 6.7 | 16 Mar 2025 |
| BAC Water | X N/A | 1 | 5.0 | 5.0 | 5.0 | 13 Jun 2025 |
| BMK ethyl glycidate CAS 41232-97-7 | X N/A | 1 | 5.6 | 5.6 | 5.6 | 20 Jun 2025 |
| Boldenone Cypionate | X N/A | 1 | 4.0 | 2.9 | 2.9 | 21 May 2025 |
| Botulinum toxin | X N/A | 1 | 8.5 | 8.5 | 8.5 | 17 Dec 2024 |
| BPC-157 Arg Oral | X N/A | 1 | 6.3 | 6.3 | 6.3 | 25 Apr 2025 |
| BPC-157 Capsule | X N/A | 1 | 6.4 | 6.4 | 6.4 | 13 Jun 2025 |
| Cabergoline | X N/A | 1 | 6.9 | 6.9 | 6.9 | 16 Mar 2025 |
| Clenbuterol | X N/A | 1 | 6.0 | 6.0 | 6.0 | 2 Jul 2025 |
| Enclomiphene | X N/A | 1 | 6.9 | 6.9 | 6.9 | 9 Jun 2025 |
| Epithalon | X N/A | 1 | 6.1 | 6.1 | 6.1 | 7 May 2025 |
| Ivermectin | X N/A | 1 | 5.0 | 5.0 | 5.0 | 2 Jul 2025 |
| KPV Oral | X N/A | 1 | 7.6 | 7.6 | 7.6 | 14 Jan 2025 |
| Lipo-C FAT BLASTER | X N/A | 1 | 8.0 | 8.0 | 8.0 | 27 Feb 2025 |
| MENT (Trestolone Acetate) | X N/A | 1 | 4.0 | 2.5 | 2.5 | 17 Dec 2024 |
| Methylamine hydrochloride CAS 593-51-1 | X N/A | 1 | 6.2 | 6.2 | 6.2 | 16 Mar 2025 |
| MGF | X N/A | 1 | 6.9 | 6.9 | 6.9 | 14 Jan 2025 |
| NA Selank Amidate | X N/A | 1 | 4.1 | 4.1 | 4.1 | 3 Jun 2025 |
| NAD+ | X N/A | 1 | 5.5 | 5.5 | 5.5 | 21 May 2025 |
| Oxytocin Acetate | X N/A | 1 | 6.6 | 6.6 | 6.6 | 24 Apr 2025 |
| PE 22-28 | X N/A | 1 | 6.1 | 6.1 | 6.1 | 14 Jan 2025 |
| Primobolan Oral (Methenolone Acetate) | X N/A | 1 | 6.4 | 6.4 | 6.4 | 7 May 2025 |
| Prostamax | X N/A | 1 | 7.4 | 7.4 | 7.4 | 28 Mar 2025 |
| Retatrutide 5mg + Cagrilintide 5mg Blend | X N/A | 1 | 4.6 | 4.6 | 4.6 | 16 Mar 2025 |
| Selank | X N/A | 1 | 7.7 | 7.7 | 7.7 | 28 Mar 2025 |
| Semaglutide Oral | X N/A | 1 | 6.0 | 6.0 | 6.0 | 8 Jul 2025 |
| Semax | X N/A | 1 | 6.2 | 6.2 | 6.2 | 14 Jan 2025 |
| Super Shred | X N/A | 1 | 6.9 | 6.9 | 6.9 | 13 Jun 2025 |
| Superdrol | X N/A | 1 | 4.0 | 3.6 | 3.6 | 2 Apr 2025 |
| Supertest 450 | X N/A | 1 | 8.5 | 8.5 | 8.5 | 9 Jun 2025 |
| Sustanon 250 | X N/A | 1 | 7.5 | 7.5 | 7.5 | 6 May 2025 |
| Tadalafil Raw | X N/A | 1 | 6.9 | 6.9 | 6.9 | 6 May 2025 |
| TB-500 FRAG | X N/A | 1 | 4.0 | 1.6 | 1.6 | 24 Apr 2025 |
| Test Propionate | X N/A | 1 | 4.0 | 3.1 | 3.1 | 7 May 2025 |
| Thymosin Alpha-1 | X N/A | 1 | 4.5 | 4.5 | 4.5 | 13 Feb 2025 |
| Trenbolone Enanthate | X N/A | 1 | 5.0 | 5.0 | 5.0 | 3 Jul 2025 |
| Winstrol (Stanozolol) | X N/A | 1 | 5.6 | 5.6 | 5.6 | 16 Mar 2025 |
Exhibit II
Evidence Log
49 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | NA Selank Amidate | 6.2 A | 50mg | 54.7mg | +9.5% | 96.74% | kamtul | Lab D | Public |
| 25 May 2026 | Trenbolone Enanthate | 5.4 B | 250mg/ml | 264.3mg/ml | +5.7% | 97.07% | hdy8xg | Lab E | Community |
| 24 May 2026 | BMK ethyl glycidate CAS 41232-97-7 | 6.9 A | 100g | 108.6g | +8.6% | 99.11% | vgkodo | Lab G | Public |
| 24 May 2026 | Semaglutide Oral | 6.1 A | 100mg | 105.3mg | +5.3% | 96.52% | 92qrdb | Lab A | Public |
| 24 May 2026 | Winstrol (Stanozolol) | 5.7 B | 50mg | 47.4mg | -5.2% | 96.07% | 1zajtf | Lab B | Public |
| 24 May 2026 | PE 22-28 | 4.5 C | 30mg | 27.4mg | -8.6% | 95.74% | 1p60mw | Lab B | Public |
| 24 May 2026 | Semax | 8.2 A | 2mg | 2.3mg | +16.5% | 95.13% | sst6x0 | Lab E | Public |
| 24 May 2026 | 1-Boc-4-AP (tert-butyl 4-(phenylamino)piperidine-1-carboxylate) CAS 125541-22-2 | 6.6 A | 10g | 9.2g | -8.5% | 99.17% | faeuf5 | Lab G | Community |
| 24 May 2026 | BPC-157 Arg Oral | 5.9 B | 20mg | 20.4mg | +2.2% | 95.49% | 6jac6r | Lab C | Public |
| 24 May 2026 | MGF | 7.9 A | 10mg | 12.3mg | +23.2% | 95.83% | m6kgq7 | Lab G | Public |
| 24 May 2026 | Botulinum toxin | 9.6 A | 30mg | 36.8mg | +22.5% | 98.64% | 567fw4 | Lab C | Public |
| 23 May 2026 | Clenbuterol | 5.6 B | 25mg | 25.4mg | +1.7% | 95.65% | uffmn0 | Lab G | Community |
| 23 May 2026 | NAD+ | 6.7 A | 10mg | 9.8mg | -1.9% | 95.72% | q18y1j | Lab F | Public |
| 21 May 2026 | Boldenone Cypionate | 4.0 C | 300mg/ml | 289.2mg/ml | -3.6% | 99.92% | fjsp0j | Lab C | Community |
| 21 May 2026 | Epithalon | 6.4 A | 20mg | 20.2mg | +1.2% | 99.12% | ywfkov | Lab D | Community |
| 21 May 2026 | Enclomiphene | 6.8 A | 100mg | 90.4mg | -9.6% | 98.63% | iddwkn | Lab C | Community |
| 20 May 2026 | Adipotide | 8.1 A | 5mg | 6.2mg | +24.6% | 99.75% | ukqqgs | Lab G | Public |
| 20 May 2026 | Cabergoline | 6.8 A | 20mg | 18.1mg | -9.5% | 95.43% | i0nwhh | Lab D | Public |
| 20 May 2026 | Tadalafil Raw | 5.6 B | 100g | 107.0g | +7.0% | 99.43% | xgpcmj | Lab F | Community |
| 19 May 2026 | Lipo-C FAT BLASTER | 10.0 A | 300mg/ml | 258.7mg/ml | -13.8% | 97.80% | re9lvu | Lab C | Public |
| 29 Jan 2026 | Alprostadil | 8.9 A | 10mg | 8.7mg | -12.9% | 98.45% | n1lga4 | Lab D | Public |
| 29 Jan 2026 | Supertest 450 | 8.9 A | 200mg/ml | 222.2mg/ml | +11.1% | 95.24% | l5a1pg | Lab D | Community |
| 26 Jan 2026 | TB-500 FRAG | 4.6 C | 2mg | 2.0mg | +0.9% | 99.20% | hrn63o | Lab G | Community |
| 19 Jan 2026 | Tirzepatide | 4.9 D | 30mg | 37.6mg | +25.3% | 99.95% | (no batch ID) | Lab E | Public |
| 7 Jan 2026 | 1-Testosterone Cypionate (DHB) Raw | 5.1 B | 100g | 121.3g | +21.3% | 99.22% | qrgbqm | Lab E | Public |
| 7 Jan 2026 | Oxytocin Acetate | 7.8 A | 10mg | 11.4mg | +14.1% | 97.40% | i03d9k | Lab C | Public |
| 7 Jan 2026 | Retatrutide 5mg + Cagrilintide 5mg Blend | 6.5 A | 20mg | 21.3mg | +6.7% | 99.39% | 5ru7z0 | Lab E | Public |
| 6 Jan 2026 | KPV Oral | 8.6 A | 10mg | 9.3mg | -7.0% | 96.75% | nca7hh | Lab G | Community |
| 12 Dec 2025 | Prostamax | 4.6 C | 5mg | 5.7mg | +13.1% | 99.15% | jdoi9w | Lab F | Public |
| 25 Nov 2025 | Tirzepatide | 7.6 A | 40mg | 42.5mg | +6.3% | 99.95% | (no batch ID) | Lab E | Public |
| 23 Nov 2025 | Selank | 9.3 A | 30mg | 34.6mg | +15.3% | 97.95% | ey0xe8 | Lab F | Community |
| 23 Nov 2025 | Test Propionate | 4.0 C | 300mg/ml | 288.8mg/ml | -3.7% | 96.76% | jvd9ox | Lab G | Public |
| 17 Nov 2025 | Sustanon 250 | 6.8 A | 250mg/ml | 260.4mg/ml | +4.2% | 98.80% | lekn43 | Lab F | Public |
| 14 Nov 2025 | BAC Water | 5.7 B | 15mg | 13.8mg | -8.1% | 99.66% | zgkvju | Lab A | Public |
| 14 Nov 2025 | BPC-157 Capsule | 6.0 A | 25mg | 23.8mg | -4.6% | 99.41% | mtrwa7 | Lab E | Public |
| 14 Nov 2025 | Ivermectin | 4.7 C | 20mg | 17.1mg | -14.4% | 95.05% | ac70ix | Lab C | Public |
| 14 Nov 2025 | Thymosin Alpha-1 | 4.0 C | 15mg | 16.1mg | +7.1% | 95.35% | qkny73 | Lab A | Community |
| 5 Nov 2025 | 5-amino-1MQ | 4.0 C | 20mg | 24.8mg | +23.8% | 96.82% | ykth04 | Lab D | Public |
| 5 Nov 2025 | AICAR | 5.8 B | 30mg | 27.3mg | -9.0% | 99.67% | 9n8pij | Lab E | Public |
| 5 Nov 2025 | Super Shred | 5.7 B | 300mg/ml | 266.4mg/ml | -11.2% | 99.79% | n7pkpb | Lab C | Public |
| 5 Nov 2025 | Superdrol | 4.0 C | 10mg | 9.5mg | -4.6% | 99.60% | 99d7q5 | Lab B | Public |
| 4 Nov 2025 | Methylamine hydrochloride CAS 593-51-1 | 6.5 A | 100g | 110.7g | +10.7% | 95.62% | n7reu3 | Lab F | Community |
| 30 Oct 2025 | Tirzepatide | 6.1 B | 30mg | 33.5mg | +11.7% | 99.90% | (no batch ID) | Lab G | Public |
| 17 Oct 2025 | MENT (Trestolone Acetate) | 4.0 C | 100mg/ml | 85.8mg/ml | -14.2% | 97.43% | ls34g5 | Lab B | Community |
| 9 Oct 2025 | Tirzepatide | 8.0 A | 40mg | 41mg | +2.5% | 99.94% | (no batch ID) | Lab E | Public |
| 3 Oct 2025 | Primobolan Oral (Methenolone Acetate) | 6.8 A | 100mg | 123.0mg | +23.0% | 97.53% | qtbe3y | Lab C | Community |
| 18 Sep 2025 | Tirzepatide | 5.7 C | 30mg | 25.7mg | -14.3% | 99.88% | (no batch ID) | Lab E | Public |
| 2 Jul 2025 | Tirzepatide | 5.2 C | 30mg | 28.1mg | -6.3% | 98.66% | (no batch ID) | Lab E | Public |
| 27 Jun 2025 | Tesamorelin | 5.5 C | 10mg | 10.04mg | +0.4% | 98.53% | (no batch ID) | Lab A | Public |
— END OF EVIDENCE LOG —